SkinHealth Systems Inc. (SKIN) stock
SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$13.88−1.18 (-7.81%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
SkinHealth Systems total assets
Total assets on the balance sheet at the end of each period.
SkinHealth Systems's total assets was $486.57M at Jun 30, 2026. For fiscal 2025 it was $499.80M, down 27.1% from the year before. The highest annual figure on record is $1.22B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $499.80M | -27.1% |
| FY2024 | Dec 31, 2024 | $685.68M | -26.2% |
| FY2023 | Dec 31, 2023 | $929.11M | -7.4% |
| FY2022 | Dec 31, 2022 | $1.00B | -17.7% |
| FY2021 | Dec 31, 2021 | $1.22B | +447.0% |
| FY2020 | Dec 31, 2020 | $222.84M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $486.57M | -4.1% |
| Q1 FY2026 | Mar 31, 2026 | $473.23M | -29.8% |
| Q4 FY2025 | Dec 31, 2025 | $499.80M | -27.1% |
| Q3 FY2025 | Sep 30, 2025 | $503.64M | -28.0% |
| Q2 FY2025 | Jun 30, 2025 | $507.57M | -28.7% |
| Q1 FY2025 | Mar 31, 2025 | $673.82M | -20.2% |
| Q4 FY2024 | Dec 31, 2024 | $685.68M | -26.2% |
| Q3 FY2024 | Sep 30, 2024 | $699.55M | -28.1% |
| Q2 FY2024 | Jun 30, 2024 | $711.83M | -29.3% |
| Q1 FY2024 | Mar 31, 2024 | $844.74M | -15.1% |
| Q4 FY2023 | Dec 31, 2023 | $929.11M | -7.4% |
| Q3 FY2023 | Sep 30, 2023 | $973.07M | -11.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.01B | -17.1% |
| Q1 FY2023 | Mar 31, 2023 | $994.95M | -17.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.00B | -17.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.10B | +10.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.21B | +254.7% |
| Q1 FY2022 | Mar 31, 2022 | $1.20B | +158.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.22B | +447.0% |
| Q3 FY2021 | Sep 30, 2021 | $997.88M | +227928.9% |
| Q2 FY2021 | Jun 30, 2021 | $342.51M | – |
| Q1 FY2021 | Mar 31, 2021 | $463.53M | – |
| Q4 FY2020 | Dec 31, 2020 | $222.84M | – |
| Q3 FY2020 | Sep 30, 2020 | $437.61K | – |
See a number that looks wrong?